Take Care Health Systems expands services; now offering nebulizer treatments at clinics nationwide
CONSHOHOCKEN, Pa. Take Care Health Systems on Wednesday announced that it now is offering nebulizer treatments, when clinically appropriate, for clinic patients exhibiting acute respiratory distress.
The expansion of services stems out of conversations and the integration with the medical community; patient and provider feedback; and demonstrated market need. According to National Hospital Ambulatory Medical Care surveys, “diseases of the respiratory system” were the third-largest primary diagnosis among visits to the emergency room in 2005 and 2006, comprising 2.8% and 3.1% of all ER visits respectively.
“Take Care health professionals routinely evaluate and treat patients with respiratory symptoms including wheezing, coughing and other symptoms that could be related to bronchitis, asthma exacerbations or other respiratory illnesses,” stated Sandra Ryan chief nurse practitioner officer for Take Care Health Systems. “Offering nebulizer treatments at Take Care Clinics across the country provides our nationally certified clinicians another tool to ensure individuals and families can receive clinically appropriate care where and when it’s needed.”
Nebulizer treatments will be available year-round to patients two years of age and older at all Take Care Clinics. All nebulizer treatments will be administered, if deemed medically necessary, in conjunction with an evaluation at a Take Care Clinic.
“Over the past year, we have seen more than 300,000 cases of acute respiratory conditions,” commented Peter Miller, Take Care Health Systems president and CEO. “Nurse practitioners and physician assistants have written prescriptions for nebulizers or meter dosed inhalers for roughly 10% of visits,” he said. “Our team based approach involved conversations with the medical community, combined with feedback from our health care professionals and market research, illustrating for us that nebulizer treatments are a necessary, timely and appropriate treatment to offer in Take Care Clinics. This valuable new service provides greater convenience for those who would normally go to an emergency room or urgent care clinic, or patients traveling away from home and are in need of a nebulizer treatment.”
Generex appoints Rubinfeld as chief scientific adviser
WORCESTER, Mass. One of the original founders of biotech giant Amgen has accepted an advisory position at a company that develops drugs delivered through the inner lining of the mouth.
Generex Biotechnology Corp. announced Tuesday the appointment of Joseph Rubinfeld as chief scientific adviser. The company said Rubinfeld would help the company develop and implement product commercialization plans for its drug delivery platform and synthetic vaccine platform technology programs.
Rubinfeld has worked in pharmaceutical and consumer product development for 50 years. His work has included helping develop the antibiotic amoxicillin and the first synthetic biodegradable detergent.
Becton, Dickinson and Co. to donate insulin injections through Direct Relief
FRANKLIN LAKES, N.J. A company that develops medical devices and technology plans to donate 5 million insulin syringes and pen needles to diabetes patients struggling to manage their disease because of the economic crisis.
Becton, Dickinson and Co. announced a nationwide program Tuesday to distribute the supplies through Direct Relief to more than 1,000 community health centers and free clinics.
“To avoid the debilitating and costly complications of diabetes, patients must effectively manage their conditions,” BD Medical – Diabetes Care president Linda Tharby said in a statement. “Insulin injections often play a vital role in this daily effort, and BD believes that patients who have fallen on tough times should not forego this critical part of their treatment regimen.”